Sign in

John Lin

@johnlin08.bsky.social
209 followers 135 following 8 posts

Medical oncologist and health services researcher. Assistant Professor, MD Anderson Cancer Center

PostsRepliesMedia
John Lin @johnlin08.bsky.social · 27/05/2026
If your employer-sponsored insurance copay for a generic is over $15, then 80% of the time, you are overpaying. In @annalsofim.bsky.social , we analyzed nationwide data on employer plans vs @mcuban.bsky.social @costplusdrugs.com Here is a breakdown on who stands to save most. 🧵
152
Reposted by John Lin
benippolito.bsky.social @benippolito.bsky.social · 13/03/2025
According to MedPAC, details of the Part D redesign mean that some enrollees will hit their $2,000 OOP maximum much faster than I realized. In one example, they show how one could hit the max with just $470 in spending.
131
Reposted by John Lin
Matthew Rae @mattrae.bsky.social · 03/02/2025
If you are downloading data right now - I recommend asdfree.com. Anthony Damico has R scripts to download ~50 public surveys, create the survey design and save them locally. If you are an R user this will things go much faster!
asdfree.com
Analyze Survey Data for Free
Analyze Survey Data for Free
087
Reposted by John Lin
Stacie Dusetzina @dusetzinas.bsky.social · 17/01/2025
HHS announces the next 15 drugs to negotiate under Part D! Great to see this progress. Quite a few cancer treatments, which will mean more savings potential than in the first year's drug list (cancer drugs get limited or no rebates today). Good news for taxpayers and Medicare spending!
hhs.gov
38123
Reposted by John Lin
Ben Rome @benro.me · 17/01/2025
📰 15 more drugs up for Medicare price negotiation this year. Including the blockbuster diabetes/obesity drug semaglutide!! 💊🩺📈🧪 www.cms.gov/newsroom/pre...
cms.gov
HHS Announces 15 Additional Drugs Selected for Medicare Drug Price Negotiations in Continued Effort to Lower Prescription Drug Costs for Seniors | CMS
Medicare has selected 15 more drugs to negotiate directly with participating drug companies. Building on the success of the first round of negotiations, the aim is to lower prices for some more of the...
063
Reposted by John Lin
Aaron Schwartz @aschwartz.bsky.social · 08/01/2025
It was a pleasure to write this piece for Health Affairs on risk adjustment in Medicare. Risk adjustment modifies payments to health plans or ACOs based on patient/beneficiary characteristics. Here's a very brief summary of my thoughts🧵 www.healthaffairs.org/doi/abs/10.1...
22712
Reposted by John Lin
Larry Levitt @larrylevitt.bsky.social · 01/01/2025
Starting today, Medicare beneficiaries will have their annual out-of-pocket drug costs capped at $2,000 as a result of the Inflation Reduction Act. www.kff.org/medicare/iss...
kff.org
Millions of People with Medicare Will Benefit from the New Out-of-Pocket Drug Spending Cap Over Time | KFF
In 2025, Medicare beneficiaries will pay no more than $2,000 out of pocket for prescription drugs covered under Part D, Medicare’s outpatient drug benefit, due to a provision in the Inflation Reductio...
471011384
Reposted by John Lin
Pedro Sant’Anna @pedrosantanna.bsky.social · 30/12/2024
Here are the first five sets of slides: 01 Introduction: psantanna.com/DiD/01_Intro... 02 Classical 2x2 setup: psantanna.com/DiD/02_two_b... 03 Clustering issues: psantanna.com/DiD/03_Clust... 04 Functional form: psantanna.com/DiD/04_Funct... 05 Covariates: psantanna.com/DiD/05_Covar...
psantanna.com
50731181